Agueda M.
- Country
- Spain
- Department
- Pediatric Hematology
Research Overview
- Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
- Phase 3 Study of Imatinib with Cytotoxic Chemotherapy in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Data & Insights
Has run more than one trial at 174 of 271 partner sites.
Specializations
Pediatric Hematology and Oncology
Clinical research activity includes acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndromes, neuroblastoma, and Langerhans cell histiocytosis, with interest in treatment strategies for childhood and adolescent malignancies.
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Neuroblastoma
- Langerhans cell histiocytosis
Work in this area is linked to the management of high-risk pediatric cancers and the development of more effective anticancer therapies in children.
Breast Cancer and Solid Tumors
The investigator is involved in studies on hormone receptor-positive breast cancer, HER2-negative breast cancer, triple-negative breast cancer, HER2-positive disease, and broader advanced solid tumors.
- Hormone receptor-positive breast cancer
- HER2-negative breast cancer
- Triple-negative breast cancer
- Advanced solid tumors
Research interests also extend to metastatic breast cancer, brain metastases, and treatment innovation for gastrointestinal and genitourinary cancers.
Thoracic, Gastrointestinal, and Genitourinary Oncology
Clinical trial involvement covers non-small cell lung cancer, small cell lung cancer, colorectal cancer, gastric cancer, hepatocellular carcinoma, urothelial carcinoma, and renal cell carcinoma.
- Non-small cell lung cancer
- Colorectal cancer
- Urothelial carcinoma
- Renal cell carcinoma
This portfolio reflects active participation in thoracic oncology, digestive system cancers, and urinary tract malignancies.
Autoimmune, Inflammatory, and Immune-Mediated Diseases
Research interests include systemic lupus erythematosus, juvenile idiopathic arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, primary biliary cholangitis, and pulmonary sarcoidosis.
- Systemic lupus erythematosus
- Juvenile idiopathic arthritis
- Crohn’s disease
- Primary biliary cholangitis
The therapeutic scope also includes immune thrombocytopenia, vasculitis, and other immune-mediated inflammatory disorders.
Cardiometabolic, Respiratory, and Rare Disorders
Additional trial activity spans heart failure, atrial fibrillation, atherosclerotic cardiovascular disease, obesity, type 2 diabetes, migraine, asthma, cystic fibrosis, and chronic kidney disease.
- Heart failure
- Atherosclerotic cardiovascular disease
- Type 2 diabetes
- Chronic kidney disease
Involvement also reaches rare metabolic and neurological disorders, including Angelman syndrome, ataxia telangiectasia, and phenylketonuria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.